Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate
- 1 March 1994
- journal article
- Published by Wiley in The Prostate
- Vol. 24 (3) , 111-113
- https://doi.org/10.1002/pros.2990240302
Abstract
Human leukocyte antigens (HLA) are cell surface glycoproteins that have a significant role in the immune system. In some cancers, changes in major histocompatibility complex (MHC) class I and II expression, usually a reduction or loss of these molecules, appear to provide a mechanism whereby tumor cells may escape host immunity. HLA analysis in patients with advanced adenocarcinoma of the prostate revealed the antigens with the highest relative risk factors as DRw52, DRw53, Bw73, DR2, and B5(51). As a result, determination of HLA haplotypes may prove to be useful in determining the men with a higher risk of developing prostate cancer.Keywords
This publication has 10 references indexed in Scilit:
- Monoclonal antibody detection of a major self peptide. MHC class II complex.The Journal of Immunology, 1992
- COMPLEXITY IN THE MAJOR HISTOCOMPATIBILITY COMPLEXInternational Journal of Immunogenetics, 1992
- Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinomaBritish Journal of Cancer, 1991
- Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reactionCancer, 1991
- Frequencies of HLA-DP alleles in the four major types of leukaemiaTissue Antigens, 1989
- More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3British Journal of Haematology, 1988
- HLA associations with leukemiaBlood, 1987
- Familial factors affecting prostatic cancer risk and plasma sex-steroid levelsThe Prostate, 1985
- Familial Prostatic Cancer Risk and Low Testosterone*Journal of Clinical Endocrinology & Metabolism, 1982
- Presensitization and kidney transplant failuresPostgraduate Medical Journal, 1971